{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:11:04Z","timestamp":1790719864780,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biofilm"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bioflm.2024.100189","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T17:43:48Z","timestamp":1709228628000},"page":"100189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Efficacy of rifampicin combination therapy against MRSA prosthetic vascular graft infections in a rat model"],"prefix":"10.1016","volume":"7","author":[{"given":"Mikkel Illemann","family":"Johansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiken Engelbrecht","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Faddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Marthinsen","family":"Seefeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Alexandrovich","family":"Mitkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6485-5134","authenticated-orcid":false,"given":"Rikke Louise","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6153-2604","authenticated-orcid":false,"given":"Nis Pedersen","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioflm.2024.100189_bib1","doi-asserted-by":"crossref","first-page":"ofac054","DOI":"10.1093\/ofid\/ofac054","article-title":"Long-term prognosis following vascular graft infection: a 10-year cohort study","volume":"9","author":"Sixt","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bioflm.2024.100189_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1469-0691.2011.03618.x","article-title":"Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study","volume":"18","author":"Legout","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bioflm.2024.100189_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejvs.2019.10.016","article-title":"'s choice - European society for vascular surgery (ESVS) 2020 clinical practice guidelines on the management of vascular graft and endograft infections","volume":"59","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.bioflm.2024.100189_bib4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cid\/ciy956","article-title":"Inadequate perioperative prophylaxis and postsurgical complications after graft implantation are important risk factors for subsequent vascular graft infections: prospective results from the vascular graft infection cohort study","volume":"69","author":"Anagnostopoulos","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bioflm.2024.100189_bib5","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/jac\/dki382","article-title":"Diagnosis and treatment of prosthetic aortic graft infections: confusion and inconsistency in the absence of evidence or consensus","volume":"56","author":"FitzGerald","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2024.100189_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0023-2018","article-title":"Staphylococcal biofilms","volume":"6","author":"Otto","year":"2018","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.bioflm.2024.100189_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrmicro1557","article-title":"Persister cells, dormancy and infectious disease","volume":"5","author":"Lewis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bioflm.2024.100189_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","article-title":"Distinguishing between resistance, tolerance and persistence to antibiotic treatment","volume":"14","author":"Brauner","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bioflm.2024.100189_bib9","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMra035415","article-title":"Treatment of infections associated with surgical implants","volume":"350","author":"Darouiche","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bioflm.2024.100189_bib10","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group","volume":"279","author":"Zimmerli","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.bioflm.2024.100189_bib11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bioflm.2024.100189_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01746-18","article-title":"Role of rifampin against staphylococcal biofilm infections in vitro, in animal models, and in orthopedic-device-related infections","volume":"63","author":"Zimmerli","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2024.100189_bib13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/jac\/dkx467","article-title":"Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria","volume":"73","author":"Liu","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2024.100189_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12860-020-00316-8","article-title":"MazEF-rifampicin interaction suggests a mechanism for rifampicin induced inhibition of persisters","volume":"21","author":"Alexander","year":"2020","journal-title":"BMC Mol Cell Biol"},{"key":"10.1016\/j.bioflm.2024.100189_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s15010-020-01551-z","article-title":"Use of rifampicin and graft removal are associated with better outcomes in prosthetic vascular graft infection","volume":"49","author":"Coste","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.bioflm.2024.100189_bib16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/1471-2334-14-228","article-title":"Factors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin","volume":"14","author":"Legout","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bioflm.2024.100189_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0287671","article-title":"Fibrinolytic and antibiotic treatment of prosthetic vascular graft infections in a novel rat model","volume":"18","author":"Johansen","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.bioflm.2024.100189_bib18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(06)68231-7","article-title":"Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus","volume":"367","author":"Diep","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bioflm.2024.100189_bib19","series-title":"The prokaryotes: a handbook on the biology of bacteria: ecophysiology, isolation, identification, applications","first-page":"3352","author":"Widdel","year":"1992"},{"key":"10.1016\/j.bioflm.2024.100189_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2024.100189_bib21","article-title":"A novel high-throughput assay identifies small molecules with activity against persister cells","author":"Petersen","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.bioflm.2024.100189_bib22","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1128\/AAC.02720-13","article-title":"Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats","volume":"58","author":"Poeppl","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2024.100189_bib23","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/AAC.01570-12","article-title":"Fosfomycin-daptomycin and other fosfomycin combinations as alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus","volume":"57","author":"Garrig\u00f3s","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2024.100189_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01865-19","article-title":"Activity of different antistaphylococcal therapies, alone or combined, in a rat model of methicillin-resistant Staphylococcus epidermidis osteitis without implant","volume":"64","author":"Albac","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2024.100189_bib25","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.1128\/AAC.01248-16","article-title":"Activity of tedizolid in methicillin-resistant Staphylococcus aureus experimental foreign body-associated osteomyelitis","volume":"60","author":"Park","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2024.100189_bib26","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1093\/jac\/dkaa163","article-title":"Efficacy of dalbavancin against MRSA biofilms in a rat model of orthopaedic implant-associated infection","volume":"75","author":"Silva","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2024.100189_bib27","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1128\/AAC.02420-12","article-title":"High activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model","volume":"58","author":"Mihailescu","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2024.100189_bib28","doi-asserted-by":"crossref","DOI":"10.1088\/1748-6041\/3\/3\/034003","article-title":"Biofilm formation, bacterial adhesion and host response on polymeric implants--issues and prevention","volume":"3","author":"Pavithra","year":"2008","journal-title":"Biomed Mater"},{"key":"10.1016\/j.bioflm.2024.100189_bib29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ajpath.2016.10.005","article-title":"A novel mouse model of Staphylococcus aureus vascular graft infection: noninvasive imaging of biofilm development in vivo","volume":"187","author":"Van de Vyver","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bioflm.2024.100189_bib30","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1128\/AAC.00047-09","article-title":"Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin","volume":"53","author":"John","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2024.100189_bib31","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1128\/AAC.00675-11","article-title":"Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus","volume":"55","author":"Saleh-Mghir","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2024.100189_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms5020021","article-title":"Hyperbaric oxygen therapy is ineffective as an adjuvant to daptomycin with rifampicin treatment in a murine model of Staphylococcus aureus in implant-associated osteomyelitis","volume":"5","author":"J\u00f8rgensen","year":"2017","journal-title":"Microorganisms"},{"key":"10.1016\/j.bioflm.2024.100189_bib33","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/jac\/dkv496","article-title":"New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection","volume":"71","author":"Revest","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2024.100189_bib34","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/AAC.47.4.1318-1323.2003","article-title":"Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects","volume":"47","author":"Dvorchik","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2024.100189_bib35","doi-asserted-by":"crossref","first-page":"8173","DOI":"10.1073\/pnas.1509743112","article-title":"Antibiotic efficacy is linked to bacterial cellular respiration","volume":"112","author":"Lobritz","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bioflm.2024.100189_bib36","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1128\/AAC.02135-12","article-title":"Arrested protein synthesis increases persister-like cell formation","volume":"57","author":"Kwan","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2024.100189_bib37","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/JCM.37.6.1771-1776.1999","article-title":"The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms","volume":"37","author":"Ceri","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bioflm.2024.100189_bib38","article-title":"Growing and analyzing biofilms in flow cells","volume":"1","author":"Sternberg","year":"2006","journal-title":"Curr Protoc Microbiol"}],"container-title":["Biofilm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590207524000145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590207524000145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T22:43:02Z","timestamp":1718577782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590207524000145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":38,"alternative-id":["S2590207524000145"],"URL":"https:\/\/doi.org\/10.1016\/j.bioflm.2024.100189","relation":{},"ISSN":["2590-2075"],"issn-type":[{"value":"2590-2075","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of rifampicin combination therapy against MRSA prosthetic vascular graft infections in a rat model","name":"articletitle","label":"Article Title"},{"value":"Biofilm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioflm.2024.100189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100189"}}